Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 66.00M | $ 45.80M | $ 99.90M | $ 79.60M | $ 67.50M |
Total Assets | $ 641.60M | $ 588.10M | $ 615.30M | $ 558.60M | $ 549.50M |
Total Debt | $ 32.10M | $ 24.60M | $ 15.90M | $ 14.40M | $ 7.10M |
Net Debt | $ -33.90M | $ -21.20M | $ -84.00M | $ -65.20M | $ -60.40M |
Total Liabilities | $ 151.00M | $ 117.50M | $ 103.60M | $ 74.40M | $ 68.50M |
Stockholders Equity | $ 488.80M | $ 468.40M | $ 509.20M | $ 481.50M | $ 478.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |